Department of Clinical Neurosciences, Service of Neurosurgery, Lausanne University Hospital (CHUV), 46 rue du Bugnon, 1011, Lausanne, Switzerland.
Department of Neurosurgery, Inselspital, University of Bern, Bern, Switzerland.
Acta Neurochir (Wien). 2019 Apr;161(4):769-779. doi: 10.1007/s00701-019-03812-9. Epub 2019 Jan 25.
The treatment of ruptured posterior circulation aneurysms remains challenging despite progresses in the endovascular and neurosurgical techniques.
To provide epidemiological characterization of subjects presenting with ruptured posterior circulation aneurysms in Switzerland and thereby assessing the treatment patterns and neurological outcomes.
This is a retrospective analysis of the Swiss SOS registry for patients with aneurysmal subarachnoid hemorrhage. Patients were divided in 3 groups (upper, lower, and middle third) according to aneurysm location. Clinical, radiological, and treatment-related variables were identified and their impact on the neurological outcome was determined.
From 2009 to 2014, we included 264 patients with ruptured posterior circulation aneurysms. Endovascular occlusion was the most common treatment in all 3 groups (72% in the upper third, 68% in the middle third, and 58.8% in the lower third). Surgical treatment was performed in 11.3%. Favorable outcome (mRS ≤ 3) was found in 56% at discharge and 65.7% at 1 year. No significant difference in the neurological outcome were found among the three groups, in terms of mRS at discharge (p = 0.20) and at 1 year (p = 0.18). High WFNS grade, high Fisher grade at presentation, and rebleeding before aneurysm occlusion (p = 0.001) were all correlated with the risk of unfavorable neurological outcome (or death) at discharge and at 1 year.
In this study, endovascular occlusion was the principal treatment, with a favorable outcome for two-thirds of patients at discharge and at long term. These results are similar to high volume neurovascular centers worldwide, reflecting the importance of centralized care at specialized neurovascular centers.
尽管血管内和神经外科技术取得了进步,破裂的后循环动脉瘤的治疗仍然具有挑战性。
提供瑞士破裂后循环动脉瘤患者的流行病学特征,从而评估治疗模式和神经预后。
这是瑞士 SOS 动脉瘤性蛛网膜下腔出血登记处的一项回顾性分析。根据动脉瘤位置将患者分为 3 组(上、中、下三分之一)。确定了临床、影像学和治疗相关变量,并确定了它们对神经预后的影响。
2009 年至 2014 年,我们纳入了 264 例破裂的后循环动脉瘤患者。血管内闭塞是所有 3 组中最常见的治疗方法(上三分之一组为 72%,中三分之一组为 68%,下三分之一组为 58.8%)。手术治疗占 11.3%。出院时良好结局(mRS≤3)为 56%,1 年时为 65.7%。在出院时 mRS(p=0.20)和 1 年时 mRS(p=0.18)方面,3 组之间的神经预后无显著差异。高 WFNS 分级、高 Fisher 分级和动脉瘤闭塞前再出血(p=0.001)与出院和 1 年时不良神经结局(或死亡)的风险相关。
在这项研究中,血管内闭塞是主要治疗方法,三分之二的患者在出院时和长期预后良好。这些结果与全球许多大容量神经血管中心相似,反映了在专门的神经血管中心集中治疗的重要性。